Toll-like receptors and surgical disease

Surgery

Volumn 131, Issue 5, 2002, Pages 477-483

  Raeburn, Christopher D ^a   Calkins, Casey M ^a   Zimmerman, Michael A ^a   Arya, Jyoti ^a   Barsness, Katherine A ^a   Harken, Alden H ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR;

CANCER IMMUNOTHERAPY; ENTERITIS; HEART SURGERY; IMMUNE RESPONSE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; TRANSPLANTATION;

EID: 0036251147     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.121096     Document Type: Article

References (59)

1. Sensing pathogens and tuning immune responses
2. Phylogenetic perspectives in innate immunity
3. Innate immunity: The virtues of a nonclonal system of recognition
4. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
5. Genetic còntrol of leucocyte responses to endotoxin
6. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides
7. Detection and analysis of the 80-kd lipopolysaccharide receptor in macrophages derived from Lpsn and Lpsd mice
8. Enhancement of murine macrophage binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein
9. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein
10. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
11. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
12. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
13. New therapeutic targets revealed through investigations of innate immunity
14. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains
15. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
16. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
17. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2
18. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
19. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
20. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
21. Induction of direct antimicrobial activity through mammalian toll-like receptors
22. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae
23. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors
24. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex
25. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses
26. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
27. Fly development genes lead to immune find
28. Tolerance, danger, and the extended family
29. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex
30. Endocytosed heat shock protein 60s use TLR2 and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells
31. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes
32. Endotoxin-resistant mice are protected from PAF-induced bowel injury and death. Role of TNF, complement activation, and endogenous PAF production
33. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes
34. Micrococci and peptidoglycan activate TLR2→ MyD88→ IRAK→ TRAF→ NIK→ IKK→ NF-kappaB signal transduction pathway that induces transcription of interleukin-8
35. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B
36. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling
37. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
38. The biology of Toll-like receptors
39. Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide-hyporesponsive C3H/HeJ mice with Klebsiella infection
40. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
41. An essential role of the NF-kappab/toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells
42. Cutting edge: Naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling
43. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
44. Apoptosis in the failing human heart
45. Apoptosis in human acute myocardial infarction
46. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation
47. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo
48. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors
49. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2
50. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells
51. Immunofriendly use of BCG-CWS-cell wall skeleton remarkably improves the survival rate of various cancer patients
52. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial
53. Adjuvanticity of mycobacterial cell walls
54. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: Involvement of toll-like receptors
55. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
56. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
57. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors
58. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease
59. An engineered human antibody to TNF (CDP571) for active Crohn's disease: A randomized double-blind placebo-controlled trial